I

Isomorphic Labs

AI-powered drug discovery and development

Technical Program Manager - Drug Discovery

Program ManagementConfirmed live in the last 24 hours
Full-timeCambridge, MA, USANo salary listed

About the Job

Requirements

  • At least a Bachelor of Science in Biology, Chemistry, or a related discipline.
  • Proven industry experience contributing to, managing, or leading early-stage or discovery small-molecule, glue, or peptide drug-design programs.
  • Understanding of small-molecule, glue, or peptide drug-discovery and development processes in the context of project and program planning and governance.
  • Experience managing budgets, including planning, forecasting, monitoring, troubleshooting, and identifying efficiencies.
  • Experience with operational program-management processes.
  • Experience with program risk management.
  • Experience supporting teams in fast-paced and constantly changing environments.

Responsibilities

  • Support Drug Design and Medical Research with program planning, dynamically monitoring timelines, tracking actions, reporting risks, driving effective meetings, and managing stakeholders.
  • Manage and monitor program budgets, including forecasting and actual spend, to support program teams, Drug Design and Medical Research, and the Technical Program Management team; report to senior stakeholders.
  • Help program teams liaise effectively with contract research organizations and other external providers or partners, including supporting contract reviews and processing.
  • Help build and embed processes and operating systems, ensuring integration and alignment across the company.

Desired Qualifications

  • An advanced degree in Biology, Chemistry, or a related discipline.
  • A program-management qualification.
  • Experience working in a machine-learning drug-discovery environment.
  • Experience working with Jira, Confluence, or other program-management software.

About the Company

Isomorphic Labs

AI-powered drug discovery and development

Isomorphic Labs uses artificial intelligence to speed up drug discovery and development. It applies machine learning and computational methods—building predictive and generative models—to accelerate how drugs are designed and how medical research is conducted. The company differentiates itself by combining the AI breakthroughs from Google DeepMind with Alphabet backing, enabling fast experimentation and scaling across biology while maintaining startup-style agility. Its goal is to bring safer, more effective therapies to market more quickly by advancing AI-driven medicine using deep learning, reinforcement learning, and other advanced techniques.

Company size
201-500
Company stage
Series C
Total funding
$7.7B
Headquarters
London, United Kingdom
Founded
2021

Recently Posted Jobs

Explore more opportunities at Isomorphic Labs

See more jobs